Literature DB >> 29714121

How advances in personalized medicine will change rheumatology.

Carlo Selmi1,2, Elizaveta Kon3,4, Maria De Santis1, Ennio G Favalli5, Rolando Cimaz6,7, Elena Generali1, Luigi Sinigaglia5.   

Abstract

Keywords:  connective tissue disease; osteoarthritis; pediatric rheumatology; psoriatic arthritis; rheumatoid arthritis; spondyloarthritis

Mesh：

Year:  2018        PMID： 29714121     DOI： 10.2217/pme-2017-0079

Source DB:  PubMed          Journal:  Per Med        ISSN： 1741-0541            Impact factor:   2.512


× No keyword cloud information.
  3 in total

Review 1.  Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.

Authors:  Chiara Crotti; Elena Agape; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

2.  Innovative Techniques to Enhance Musculoskeletal Surgery Outcomes.

Authors:  Berardo Di Matteo; Peter Angele; Christian Lattermann; Elizaveta Kon
Journal:  Biomed Res Int       Date:  2018-11-13       Impact factor: 3.411

Review 3.  Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis.

Authors:  Ennio G Favalli
Journal:  Rheumatol Ther       Date:  2020-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.